Literature DB >> 6205035

Gastrin induces histamine release from human cutaneous mast cells.

M D Tharp, R Thirlby, T J Sullivan.   

Abstract

Physiologic concentrations of human gastrin I (G17) and a synthetic analog of the carboxy-terminal region of gastrin, pentagastrin, provoked a dose-related release of histamine from human cutaneous mast cells in vitro. The N-terminal tridecapeptide portion of gastrin (G1-13) neither stimulated histamine release nor blocked the action of G17. In vivo correlation studies demonstrated that low concentrations (10(-12)M to 10(-10)M) of G17 or pentagastrin administered intradermally provoked a modest but definite wheal-and-flare response in four out of six normal subjects and a more marked, dose-related response in a patient with mastocytosis. These results indicate that physiologic concentrations of gastrin can stimulate mediator release from human cutaneous mast cells. We propose that this response may be mediated through receptors recognizing the carboxy-terminal region of the gastrin molecule. The possible role of gastrin-induced human mast cell-mediator release should be considered in the assessment of allergic disorders and in experimental models investigating mast cell function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205035     DOI: 10.1016/0091-6749(84)90280-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

1.  Gastric hypersecretion associated to iodoacetamide-induced mild gastritis in mice.

Authors:  L Piqueras; J M Corpa; J Martínez; V Martínez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-23       Impact factor: 3.000

Review 2.  Exercise-Induced Anaphylaxis: Literature Review and Recent Updates.

Authors:  Matthew P Giannetti
Journal:  Curr Allergy Asthma Rep       Date:  2018-10-26       Impact factor: 4.806

3.  The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.

Authors:  N J Hayward; M Harding; S A Lloyd; A T McKnight; J Hughes; G N Woodruff
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

4.  Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity.

Authors:  K Folkers; D M Feng; N Asano; R Håkanson; Z Weisenfeld-Hallin; S Leander
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

5.  Concentrations of gastric mucosal cytokines in children with food allergy and Helicobacter pylori infection.

Authors:  Elzbieta Maciorkowska; Anatol Panasiuk; Maciej Kaczmarsk
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

Review 6.  Chronic urticaria in adults: state-of-the-art in the new millennium.

Authors:  Paulo Ricardo Criado; Roberta Facchini Jardim Criado; Celina Wakisaka Maruta; Vitor Manoel Silva dos Reis
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

7.  Exercise-induced anaphylaxis: a case report and review of the diagnosis and treatment of a rare but potentially life-threatening syndrome.

Authors:  Nathan T Jaqua; Matthew R Peterson; Karla L Davis
Journal:  Case Rep Med       Date:  2013-03-27

8.  Long-term omalizumab use in the treatment of exercise-induced anaphylaxis.

Authors:  Mark R Peterson; Christopher A Coop
Journal:  Allergy Rhinol (Providence)       Date:  2017-10-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.